Melanoma
From the Journals
Immunotherapy regimen influences inflammatory arthritis presentation
Variations in the clinical presentation of immunotherapy-induced inflammatory arthritis is partly explained by which treatment regimen is used to...
Conference Coverage
When to worry about congenital melanocytic nevi
KAUAI, HAWAII – Childhood melanoma often doesn't follow the ABCDE signs common in adults.
Conference Coverage
VIDEO: U.S. melanoma incidence hits all-time high
Annual U.S. incidence rates of invasive and in situ melanoma steadily climbed to a new high of 178,560 cases in 2018.
Case Reports
Concurrent ipilimumab and CMV colitis refractory to oral steroids
Conference Coverage
VIDEO: Gene test guides need for sentinel node biopsy in elderly melanoma patients
With T1-T2 tumors and a Class 1A test result, SLN positivity was 1.6% in patients 65 years and older.
From the Journals
Melanoma incidence increased in older non-Hispanic whites
Skin cancer prevention efforts, which appear to have had an effect among young people, now need to target the older generation.
Conference Coverage
Be alert for BAP1 mutations in hereditary melanomas
MIAMI – They’re rare genetic mutations that can make melanoma more aggressive and lethal, as well as signal of a potentially elevated risk for...
From the Journals
Neoadjuvant dabrafenib and trametinib improves event-free survival in resectable melanoma
The phase 2 trial was closed early due to the difference in event-free survival favoring the neoadjuvant approach.
Feature
Supportive oncodermatology: Cancer advances spawn new subspecialty
Not too long ago at the Dana-Farber/Brigham and Women’s Cancer Center in Boston, a woman with widely metastatic melanoma, who had been planning...
From the Journals
Desmoplastic melanoma yields to checkpoint inhibitors
Of 60 patients with desmoplastic melanoma treated with checkpoint inhibitors and followed for a median of 22 months, 42 had an objective response...
News
FDA expands approval of nivolumab for melanoma treatment
Nivolumab was approved for the adjuvant treatment of melanoma patients with involvement of lymph nodes or in patients with metastatic disease who...